Canagliflozin vs Erlotinib

Canagliflozin vs Erlotinib: Overview

This comparison examines the pharmacological differences between Canagliflozin and Erlotinib.

Mechanism of Action

Canagliflozin: Selective SGLT2 inhibitor reducing renal glucose reabsorption and lowering blood glucose.

Erlotinib: Reversible inhibitor of EGFR (HER1) tyrosine kinase, blocking autophosphorylation.

Pharmacokinetics

Half-life: Canagliflozin — 10.6 hours; Erlotinib — 36 hours.

Chemical Properties

Molecular Formula: Canagliflozin — C24H25FO5S; Erlotinib — C22H23N3O4.

Molecular Weight: Canagliflozin — 444.5170 g/mol; Erlotinib — 393.4380 g/mol.

Type: Canagliflozin — Small molecule; Erlotinib — Small molecule.